Vorinostat Completed Phase 2 Trials for Nodal Marginal Zone Lymphoma / Recurrent Grade 3 Follicular Lymphoma / Recurrent Mantle Cell Lymphoma / Recurrent Marginal Zone Lymphoma / Recurrent Grade 1 Follicular Lymphoma / Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue / Recurrent Grade 2 Follicular Lymphoma Treatment